Pfizer CEO Albert Bourla said there are "opportunities that probably outweigh the risks" of the Trump administration's ...

Pfizer CEO Albert Bourla told investors he dined with RFK Jr, a vaccine skeptic and nominee to head HHS. They discussed ...

Pfizer Chairman and CEO Albert Bourla did not mince his words at the ... declined to approximately 93% over the 2020–21 and 2021–22 school years and remained essentially unchanged during ...

Investors have been cool to Pfizer, with shares down some 50% since record highs in 2021. Pfizer Chief Executive Albert Bourla has been looking to turn around the company's performance, taking steps ...

The news eases some of the pressure on Pfizer Chief Executive Officer Albert Bourla, who has insisted ... have fallen by more than 50% since 2021, as demand for its Covid medicines dried up ...

It’s time for a new era of public health—where vaccines are seen as both a scientific triumph and a shared commitment to well-being of all.

Pfizer's fourth quarter beat expectations on strong sales of its Covid vaccine and pill, bolstering its sales as it seeks to ...

Investing.com -- Pfizer Inc. (NYSE: PFE) has temporarily avoided a standoff with activist investor Starboard Value LP. According to Bloomberg sources, Starboard did not put forward any nominations for ...

Investors have been cool to Pfizer, with shares down some 50% since record highs in 2021. Pfizer Chief Executive Albert Bourla has been looking to turn around the company's performance ...

Pfizer Inc. got a reprieve — at least for now — in its battle with activist investor Starboard Value LP, according to people familiar with the matter.